Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 201–300 of 1,001
Deussing, J. M. (2006) · Drug Discovery Today: Disease Models · doi:10.1016/j.ddmod.2006.11.003 · Cited by 189
Altemus, M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010009002 · Cited by 188
Alteration in the Hypothalamic-Pituitary-Ovarian Axis in Depressed Women
Young, E. A., Midgley, A. R., Carlson, N. E., & Brown, M. B. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.12.1157 · Cited by 187
“In addition, increased CRH in the cerebrospinal fluid, which indicatesgeneralactivationof theextrahypothalamic CRH systems, has been foundindepressedpatients, lendingfurther support to a hypothesis of decreased reproductive function in depression.(17) The HPO axis, and LH secretion in particular, is characterized by e…”
Dunn, A. J., & Berridge, C. W. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90195-x · Cited by 187
Experience effects on brain development: possible contributions to psychopathology
Grossman, A. W., Churchill, J. D., McKinney, B. C., Kodish, I. M., Otte, S. L., & Greenough, W. T. (2003) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.t01-1-00102 · Cited by 186
Prenatal stress in rats predicts immobility behavior in the forced swim test
Morley-Fletcher, S., Darnaudery, M., Koehl, M., Casolini, P., Van Reeth, O., & Maccari, S. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03293-1 · Cited by 185
Adinoff, B. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810160025004 · Cited by 185
Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Jahn, H., Schick, M., Kiefer, F., Kellner, M., Yassouridis, A., & Wiedemann, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1235 · Cited by 184
Penza, K. M., Heim, C., & Nemeroff, C. B. (2003) · Archives of Women's Mental Health · doi:10.1007/s00737-002-0159-x · Cited by 184
“However, Rasmusson and colleagues (2001) found elevated ACTH responses to CRF hormone challenge tests among subjects with PTSD with mixed types of traumas.”
BackgroundInfluentialSelf-citationGenetics of Affective and Anxiety Disorders
Leonardo, E. D., & Hen, R. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.57.102904.190118 · Cited by 184
Van Praag, H. M. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030018 · Cited by 184
“/ Increased CRH concentration in plasma and CSF (Nemeroff et al. 1984; Catalán et al. 1998) (Figure 7), whereas the level of CSF CRH and dexamethasone non-suppression are positively correlated.”
InfluentialCSF corticotropin-releasing hormone in depressed patients and normal control subjects
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.5.641 · Cited by 183
The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response
Dedic, N., Chen, A., & Deussing, J. M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170302104053 · Cited by 182
“Importantly, many of these effects were independent of downstream GC effects, defining the ability of central CRF to coordinate behavioral responses independent of, or in synergism with peripheral HPA axis function [87, 100, 101].”
BackgroundOwens, M. J., & Nemeroff, C. B. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470514368.ch15 · Cited by 181
Self-citationJuruena, M. F., Cleare, A. J., & Pariante, C. M. (2004) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462004000300009 · Cited by 180
How can we realize the promise of personalized antidepressant medicines?
Holsboer, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2453 · Cited by 177
Pharmacogenetics of antidepressant response
Porcelli, S., Drago, A., Fabbri, C., Gibiino, S., Calati, R., & Serretti, A. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100059 · Cited by 177
“It has been reported that the alterations of CRH function contribute to the pathogenesis of depression: concentrations of CRH in the cerebrospinal fluid (CSF) are elevated.(310,311) Imaging studies on patients with MDD and suicidal behaviour, together with animal studies on models of depression and human studies, conf…”
ResultCorticotropin-Releasing Hormone
Taylor, A. L., & Fishman, L. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807283190405 · Cited by 176
Early Life Stress, Mood, and Anxiety Disorders
Syed, S. A., & Nemeroff, C. B. (2017) · Chronic Stress · doi:10.1177/2470547017694461 · Cited by 151
Self-citationUnexplained Weight Loss in the Ambulatory Elderly
Thompson, M. P., & Morris, L. K. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02496.x · Cited by 174
Tobacco addiction and the dysregulation of brain stress systems
Bruijnzeel, A. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.015 · Cited by 173
“Pioneering studies by Nemeroff, Koob and others showed that CRF plays a critical role in depression and drug addiction (Baldwin et al., 1991; Koob, 1996; Nemeroff et al., 1984).”
BackgroundChronic social stress: effects on limbic brain structures
Fuchs, E., & Flügge, G. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00161-6 · Cited by 173
“This probably corresponds to low CRH levels in this part of the cortex, which coincides with reports form postmortem data in depressed patients [93].”
BackgroundResultNeurobiology of resilience in depression: immune and vascular insights from human and animal studies
Dudek, K. A., Dion‐Albert, L., Kaufmann, F. N., Tuck, E., Lebel, M., & Menard, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14547 · Cited by 151
Bakshi, V. P., Smith-Roe, S., Newman, S. M., Grigoriadis, D. E., & Kalin, N. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02926.2002 · Cited by 171
“Patients with stress-related problems such as depression often have alterations in their CRH system, suggesting that it may play an important role in stress-related psychopathology (Nemeroff et al., 1984; Mitchell, 1998).”
BackgroundMelia, K. R., & Duman, R. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8382 · Cited by 170
Regulation of Serotonin Release in the Lateral Septum and Striatum by Corticotropin-Releasing Factor
Price, M. L., & Lucki, I. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02833.2001 · Cited by 169
“Taken together with reports that CRF is hypersecreted in depressed patients or in suicide victims (Nemeroff et al., 1984; Banki et al., 1987), with reports of reduced numbers of CRF receptors in the brains of suicide victims (Nemeroff et al.”
BackgroundGlucocorticoids Orchestrate Divergent Effects on Mood through Adult Neurogenesis
Lehmann, M. L., Brachman, R. A., Martinowich, K., Schloesser, R. J., & Herkenham, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3878-12.2013 · Cited by 168
“Stress-relateddisordersare associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA)axis,manifestedasabnormaladrenalglucocorticoid(GC)secretion and disrupted hormone feedback loops (Nemeroff et al., 1984; Holsboer et al., 1987).”
BackgroundLicinio, J., O'Kirwan, F., Irizarry, K., Merriman, B., Thakur, S., Jepson, R., Lake, S., Tantisira, K. G., Weiss, S. T., & Wong, M.-L. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 168
Depression and anxiety: Role of the locus coeruleus and corticotropin-releasing factor
Weiss, J. M., Stout, J. C., Aaron, M. F., Quan, N., Owens, M. J., Butler, P. D., & Nemeroff, C. B. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90170-8 · Cited by 168
Self-citationNeuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167
Assessment and treatment of depression in the cancer patient
Newport, D. J., & Nemeroff, C. B. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(98)00011-7 · Cited by 167
Self-citationType 1 diabetes mellitus and major depressive disorder: evidence for a biological link
Korczak, D. J., Pereira, S., Koulajian, K., Matejcek, A., & Giacca, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2240-3 · Cited by 181
“The functional abnormalities of the HPA axis in the depressed state are well described and include increased plasma cortisol concentrations [88], an enlarged adrenal cortex [89] and elevated concentrations of cortisol and corticotropin-releasing factor in the cerebrospinal fluid [90].”
BackgroundIncreased pituitary activation following metyrapone administration in post-traumatic stress disorder
Yehuda, R., Levengood, R. A., Schmeidler, J., Wilson, S., Song Guo, L., & Gerber, D. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00055-0 · Cited by 166
Adult Hippocampal Neurogenesis: Regulation and Possible Functional and Clinical Correlates
Baptista, P., & Andrade, J. P. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00044 · Cited by 164
Linthorst, A. C. E., Flachskamm, C., Hopkins, S. J., Hoadley, M. E., Labeur, M. S., Holsboer, F., & Reul, J. M. H. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04448.1997 · Cited by 163
“Indeed, patients suffering from major depression show elevated levels of CRH in the cerebrospinal fluid (Nemeroff et al., 1984), increased numbers of CRH and CRH/vasopressinexpressing neurons in their paraventricular nucleus (PVN) (Raadsheer et al., 1994), elevated CRH mRNA levels in this…”
Austin, M. C., Janosky, J. E., & Murphy, H. A. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001250 · Cited by 162
The neuropsychopharmacological potential of neuroactive steroids
Rupprecht, R. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00060-x · Cited by 162
Neuropeptides in neurological disease
Beal, M. F., & Martin, J. B. (1986) · Annals of Neurology · doi:10.1002/ana.410200502 · Cited by 162
Irwin, M. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810200021003 · Cited by 161
Magnesium and Affective Disorders
Murck, H. (2002) · Nutritional Neuroscience · doi:10.1080/1028415021000039194 · Cited by 157
“This assumption is supported by measurements of the CRH concentration in the CSF: Nemeroff reported a significant increase in comparison to controls (Nemeroff et al., 1984).”
ResultHypercortisolism and its possible neural bases
Sapolsky, R. M., & Plotsky, P. M. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90032-w · Cited by 161
Sex Differences in Molecular and Cellular Substrates of Stress
Bangasser, D. A., & Valentino, R. J. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9824-4 · Cited by 160
“Consequences of these sex differences would be magnified when CRF is in excess as has been proposed in depression and PTSD.”
InfluentialMerali, Z., Kent, P., Du, L., Hrdina, P. D., Palkovits, M., Faludi, G., Poulter, M. O., Bédard, T., & Anisman, H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.008 · Cited by 176
Glucocorticoids and depression
Steckler, T., Holsboer, F., & Reul, J. M. H. M. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0046 · Cited by 159
Depression and Endocrine Disorders: Focus on the Thyroid and Adrenal System
Musselman, D. L., & Nemeroff, C. B. (1996) · British Journal of Psychiatry · doi:10.1192/s0007125000298504 · Cited by 156
Self-citationInnovative Approaches for the Treatment of Depression: Targeting the HPA Axis
THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 171
“Elevation of CRF concentrations in the cerebrospinal fluid (CSF) of patients suffering from depression, PTSD and obsessive compulsive disorder have also been observed [26, 34, 48].”
BackgroundReduced Neuropeptide Y Concentrations in Suicide Brain
Widdowson, P. S., Ordway, G. A., & Halaris, A. E. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08877.x · Cited by 155
Holsboer, F., Spengler, D., & Heuser, I. (1992) · Progress in Brain Research · doi:10.1016/s0079-6123(08)64586-0 · Cited by 159
Stress and Disease: Is Being Female a Predisposing Factor?
Becker, J. B., Monteggia, L. M., Perrot-Sinal, T. S., Romeo, R. D., Taylor, J. R., Yehuda, R., & Bale, T. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3565-07.2007 · Cited by 158
“Although the stress response is essential for maintenance of homeostasis, maladaptive responses to stress can lead to disease, including an elevation in risk factors for depression and anxiety, as well as behaviors associated with drug-taking escalation and relapse (Nemeroff et al., 1984; Nemeroff, 1988; Koob, 1999; B…”
BackgroundHormonal Evidence for Altered Responsiveness to Social Stress in Major Depression
Young, E. A., Lopez, J. F., Murphy-Weinberg, V., Watson, S. J., & Akil, H. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00129-9 · Cited by 178
“…of stress responsiveness in the brain, is elevated in CSF and hypothalamus, and that this elevation may contribute both to the endocrine and psychological profile seen in severe depression (Nemeroff et al. 1984; Roy et al. 1987; Raadsheer et al. 1995, 1994; Nemeroff, 1988; Nemeroff et al. 1988).”
BackgroundLiu, Z., Zhu, F., Wang, G., Xiao, Z., Wang, H., Tang, J., Wang, X., Qiu, D.-S., Liu, W., Cao, Z., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.06.016 · Cited by 161
Cortisol: The Culprit Prenatal Stress Variable
Field, T., & Diego, M. (2008) · International Journal of Neuroscience · doi:10.1080/00207450701820944 · Cited by 146
“Those individuals have higher concentrations of urinary and salivay cortisol (Nemeroff et al., 1984).”
BackgroundCorticotropin‐releasing hormone (CRH) in psychiatry: from stress to psychopathology
Claes, S. (2004) · Annals of Medicine · doi:10.1080/07853890310017044 · Cited by 153
Future therapeutic targets in mood disorders: the glucocorticoid receptor
McQuade, R., & Young, A. H. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.5.390 · Cited by 156
The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats
Keck, M. E., Welt, T., Wigger, A., Renner, U., Engelmann, M., Holsboer, F., & Landgraf, R. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01383.x · Cited by 154
“…et al., 1995, 1999; Heinrichs et al., 1997a) and are consistent with the notion that many signs and symptoms of depression and anxiety disorders (Nemeroff et al., 1984, 1988; Chrousos & Gold, 1992; Raadsheer et al., 1995; review: Holsboer, 1999; Keck & Holsboer, 2000) can be attributed to an…”
Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression
Pfennig, A., Kunzel, H. E., Kern, N., Ising, M., Majer, M., Fuchs, B., Ernst, G., Holsboer, F., & Binder, E. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.017 · Cited by 174
Okuyama, S., Chaki, S., Kawashima, N., Suzuki, Y., Ogawa, S.-I., Nakazato, A., Kumagai, T., Okubo, T., & Tomisawa, K. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38220-5 · Cited by 152
De La Garza, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.016 · Cited by 153
Liu, Z., Zhu, F., Wang, G., Xiao, Z., Tang, J., Liu, W., Wang, H., Liu, H., Wang, X., Ying-liang, W., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.013 · Cited by 163
von Bardeleben, U., Holsboer, F., Stalla, G. K., & Müller, O. A. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90480-1 · Cited by 162
Rincón-Cortés, M., & Sullivan, R. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00033 · Cited by 139
“Depression is a common outcome of childhood abuse, and children with a comorbid history of depression and abuse have elevated CRF levels in the cerebrospinal fluid (313) as well as an increased ACTH response to a CRF challenge compared to children with depression without abuse, suggesting excessive CRF release (3, 314…”
BackgroundAre BDNF and glucocorticoid activities calibrated?
Jeanneteau, F., & Chao, M. V. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.017 · Cited by 141
“Elevated plasma level of glucocorticoids (hypercorticoid state) is a major endocrine hallmark of psychiatric and neurodegenerative diseases (Nemeroff et al., 1984; Holsboer, 2000; Pariante et al., 2003).”
Wichmann, S., Kirschbaum, C., Böhme, C., & Petrowski, K. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.06.005 · Cited by 159
“…showed a hyperresponse pattern in patients with a major depressive disorder (Banki, Bissette, Arato, O’Connor, & Nemeroff, 1987; Deuschle et al., 1997; Handwerger, 2009; Holsboer et al., 1984; Nemeroff et al., 1984; Pariante & Lightman, 2008; Petrowski, Wintermann, Kirschbaum, & Bornstein, 2012).”
Fortnightly review: Stress, the brain, and mental illness
Herbert, J. (1997) · BMJ · doi:10.1136/bmj.315.7107.530 · Cited by 146
Sex, Stress, and Mood Disorders: At the Intersection of Adrenal and Gonadal Hormones
Fernández-Guasti, A., Fiedler, J., Herrera, L., & Handa, R. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1312592 · Cited by 144
Harro, J., & Oreland, L. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00082-0 · Cited by 175
PSYCHONEUROENDOCRINOLOGY OF POST-TRAUMATIC STRESS DISORDER
Yehuda, R. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70010-1 · Cited by 172
Gewirtz, J. C., Mcnish, K. A., & Davis, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00028-1 · Cited by 149
Banki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90019-5 · Cited by 149
Self-citationThird Pathophysiology of Prenatal Cocaine Exposure
Lester, B. M., & Padbury, J. F. (2009) · Developmental Neuroscience · doi:10.1159/000207491 · Cited by 143
Depression and adipose essential polyunsaturated fatty acids
Mamalakis, G., Tornaritis, M. J., & Kafatos, A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0435 · Cited by 161
The hypothalamic-pituitary-adrenal axis in anorexia nervosa
Licinio, J., Wong, M.-L., & Gold, P. W. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02991-5 · Cited by 146
Psychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features
Dorn, L. D., Burgess, E. S., Dubbert, B., Simpson, S., Friedman, T., Kllng, M., Gold, P. W., & Chrousos, G. P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02614.x · Cited by 152
“, 1988a,b), supported by biochemical evidence of hypersecretion of corticotrophin releasing hormone (CRH) and cortisol (Roy et al., 1987; Nemeroff et al., 1984; Kling et al., 1991).”
BackgroundKünzel, H. E., Binder, E. B., Nickel, T., Ising, M., Fuchs, B., Majer, M., Pfennig, A., Ernst, G., Kern, N., Schmid, D. A., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300280 · Cited by 120
“…of CRH mRNA expressing neurons in the hypothalamus and a reduced CRH receptor binding capacity in the frontal cortex in post-mortem studies as well as increased CRH concentration in cerebrospinal fluid were reported for patients with depression (Nemeroff et al, 1984, 1988; Raadsheer et al, 1994).”
BackgroundAxelson, D., Doraiswamy, P. M., Boyko, O. B., Escalona, P. R., McDonald, W. M., Ritchie, J., Patterson, L. J., Ellinwood, E. H., Nemeroff, C. B., & Krishnan, K. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90070-j · Cited by 150
Self-citationGeracioti, T. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.4.637 · Cited by 125
Self-citationPsychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity
Holsboer, F. (1989) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00449812 · Cited by 160
KLING, M. A., ROY, A., DORAN, R., CALABRESE, J. R., RUBINOW, D. R., DAVID, H. J., MAY, C., POST, R. M., CHROUSOS, G. P., & GOLD, P. W. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-260 · Cited by 145
Depression and cardiovascular disease
Bradley, S. M., & Rumsfeld, J. S. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.02.002 · Cited by 160
“[37] Nemeroff CB, Widerlöv E, Bissette G, Walléus H, Karlsson I, Eklund K, et al.”
BackgroundLu, A., Steiner, M. A., Whittle, N., Vogl, A. M., Walser, S. M., Ableitner, M., Refojo, D., Ekker, M., Rubenstein, J. L. R., Stalla, G. K., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.51 · Cited by 156
Ising, M., Zimmermann, U. S., Kunzel, H. E., Uhr, M., Foster, A. C., Learned, S. M., Holsboer, F., & Grigoriadis, D. E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301328 · Cited by 153
“…symptomatology began with the observation that the cerebrospinal fluid (CSF) of depressed patients contained elevated levels of the CRF peptide (Nemeroff et al, 1984) and the demonstration that pituitary ACTH release following exogenous systemic administration of CRF was blunted among…”
Flandreau, E. I., Ressler, K. J., Owens, M. J., & Nemeroff, C. B. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.04.014 · Cited by 143
“Evidence for this possibility includes elevated CRF concentrations in cerebrospinal fluid (CSF) from psychiatric patients (Banki et al., 1992; Fossey et al., 1996; Nemeroff et al., 1984) and elevated amygdalar CRF transcript in animal models following chronic stress.”
BackgroundSelf-citationHammack, S. E., Cooper, M. A., & Lezak, K. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.024 · Cited by 142
“In contrast, MDD is associated with elevated basal cortisol and reduced DEX suppression (Nemeroff et al., 1984).”
BackgroundLinthorst, A. C. E., Peñalva, R. G., Flachskamm, C., Holsboer, F., & Reul, J. M. H. M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02400.x · Cited by 143
“These psychiatric diseases are also characterized by aberrant functioning of the hypothalamic-pituitaryadrenocortical (HPA) axis (Holsboer & Barden, 1996), probably involving increased levels of corticotropin-releasing hormone (CRH) (Nemeroff et al., 1984; Raadsheer et al., 1994; Holsboer, 1999).”
BackgroundBaram, T. A. (1993) · Annals of Neurology · doi:10.1002/ana.410330302 · Cited by 142
“Humans with depression and those with anorexia nervosa have increased CRH levels in the cerebrospinal fluid (CSF), and an abnormal CRH-ACTH-GC axis [51-53].”
BackgroundGrippo, A. J., Wu, K. D., Hassan, I., & Carter, C. S. (2008) · Depression and Anxiety · doi:10.1002/da.20375 · Cited by 138
“, 2002], and is associated with several mood- and anxiety-relevant physiological changes including neuroendocrine dysfunction [Landgraf and Wigger, 2003; Nemeroff et al., 1984; Young et al., 2004], alterations in immune function [Leonard and Song, 1996], dysregulated autonomic nervous system activity [Grippo et al.”
BackgroundLester, B. M., & Lagasse, L. L. (2010) · Journal of Addictive Diseases · doi:10.1080/10550881003684921 · Cited by 133
Miller, A. H., Spencer, R. L., Pulera, M. R., Kang, S., McEwen, B. S., & Stein, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90175-y · Cited by 152
Biomarkers of depression in cancer patients
Jehn, C. F., Kuehnhardt, D., Bartholomae, A., Pfeiffer, S., Krebs, M., Regierer, A. C., Schmid, P., Possinger, K., & Flath, B. C. (2006) · Cancer · doi:10.1002/cncr.22294 · Cited by 139
Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link?
Sierksma, A. S. R., van den Hove, D. L. A., Steinbusch, H. W. M., & Prickaerts, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.021 · Cited by 139
“It has in fact been demonstrated that MD patients have a pronounced elevation of CRH in their cerebrospinal fluid (Banki et al., 1987; Nemeroff et al., 1984; Risch et al., 1992) and a higher expression of CRH mRNA in the PVN (Raadsheer et al., 1995).”
BackgroundHPA Axis Interactions with Behavioral Systems
Packard, A. E. B., Egan, A. E., & Ulrich‐Lai, Y. M. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150042 · Cited by 151
Buwalda, Boer, D., Schmidt, Felszeghy, Nyakas, Sgoifo, der Vegt, V., Tilders, Bohus, & Koolhaas (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00350.x · Cited by 134
Two Roads to Rapid Eye Movement Latency
Kupfer, D. J. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810100087016 · Cited by 140
Elevated Concentrations of CRF in the Locus Coeruleus of Depressed Subjects
Bissette, G., Klimek, V., Pan, J., Stockmeier, C., & Ordway, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300191 · Cited by 136
“While CRF levels in lumbar CSF from depressed patients (Nemeroff et al, 1984; Banki et al, 1987) or completed suicides (Arato et al, 1989) has been repeatedly demonstrated to be elevated, CRF concentrations in lumbar CSF from subjects with a prior suicide attempt have been reported either to be…”
BackgroundSelf-citationRubinow, D. R., Crowder, V. L., Schmidt, P. J., & Rubinow, K. B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10036-8 · Cited by 138
Pépin, M.-C., Beaulieu, S., & Barden, N. (1989) · Molecular Brain Research · doi:10.1016/0169-328x(89)90031-4 · Cited by 151
Kunzel, H. E., Zobel, A. W., Nickel, T., Ackl, N., Uhr, M., Sonntag, A., Ising, M., & Holsboer, F. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00070-0 · Cited by 142
“, 2001), and by elevated levels of CRH in the cerebrospinal fluid corresponding to decreased CRH binding in the prefrontal cortex of depressed patients (Nemeroff et al., 1984; Hartline et al., 1996; Holsboer, 1999).”
BackgroundBrain-immune interactions and disease susceptibility
Marques-Deak, A., Cizza, G., & Sternberg, E. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001643 · Cited by 151
The etiology of poststroke-depression: a hypothesis involving HPA axis
Zhou, L., Wang, T., Yu, Y., Li, M., Sun, X., Song, W., Wang, Y., Zhang, C., & Fu, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113146 · Cited by 142
NEUROIMMUNOMODULATION VIA LIMBIC STRUCTURES — THE NEUROANATOMY OF PSYCHOIMMUNOLOGY
Haas, H. S., & Schauenstein, K. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00055-x · Cited by 143
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.